NCT02061358 - Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions

Viral Infection

Interventions

DRUG

UV-4B 3 mg

Oral solution, single dose

DRUG

UV-4B 10 mg

Oral solution, single dose

DRUG

UV-4B 30 mg

Oral solution, single dose

DRUG

UV-4B 90 mg

Oral solution, single dose

DRUG

UV-4B 180 mg

Oral solution, single dose

DRUG

UV-4B 360 mg

Oral solution, single dose

DRUG

UV-4B 720 mg

Oral solution, single dose

DRUG

UV-4B 1000 mg

Oral solution, single dose

DRUG

Placebo

Oral solution, single dose

Trial Locations (1)

Quintiles, Inc, Overland Park